Colin L. Masters, B MED SCI (HONS), MBBS, MD, FRCPath, FRCPA, FAA

Mental Health Research Institute University of Melbourne, Parkville, Victoria, Australia 
Alzheimer's disease, amyloid
"Colin Masters"

Executive Director and Laureate Professor
Appointed Institute Director in 2007.
Former Director of Prana Biotechnology and Laureate Professor at Melbourne University's School of Medicine

Mean distance: 18.34 (cluster 28)
Cross-listing: Alzheimer's Tree - Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hadoux X, Hui F, Lim JKH, et al. (2019) Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nature Communications. 10: 4227
Burnham SC, Loi SM, Doecke J, et al. (2019) The dawn of robust individualised risk models for dementia. The Lancet. Neurology
Baker JE, Bruns L, Hassenstab J, et al. (2019) Use of an experimental language acquisition paradigm for standardized neuropsychological assessment of learning: A pilot study in young and older adults. Journal of Clinical and Experimental Neuropsychology. 1-11
Huq AJ, Fransquet P, Laws SM, et al. (2019) Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Xiong C, Luo J, Agboola F, et al. (2019) A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Baker JE, Pietrzak RH, Laws SM, et al. (2019) Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults. Neuropsychology
Venkatraman VK, Sanderson A, Cox KL, et al. (2019) Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial. Neurobiology of Aging
Insel PS, Weiner M, Mackin RS, et al. (2019) Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology
Eratne D, Loi SM, Walia N, et al. (2019) A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists? The Australian and New Zealand Journal of Psychiatry. 4867419857811
Taswell C, Donohue C, Mastwyk MT, et al. (2019) Avoiding methodological bias in studies of amyloid imaging results disclosure. Alzheimer's Research & Therapy. 11: 52
See more...